Valneva SE
NASDAQ:VALNBiotechnology
+$0.01 today
- Market cap
- $507.98M
- Beta
- 1.40
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.80
Volume 0.00M
Average 0.09M
VALN EBITDA Margin
EBITDA as a percentage of revenue.
Valneva SENASDAQ: VALN
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -84.6%
EBITDA Margin was -84.6% in Q1 FY2026, down 80.0 pp from a year earlier. On a trailing-twelve-month basis it was -57.7%, down 35.6 pp year over year. Over 3 fiscal years it widened by 0.1 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 5 analysts of -17.5% for the fiscal year ending Dec 2026, up from -28.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -84.6%-42.7 pp QoQ
- Last fiscal yearDec 2025
- -28.9%-47.8 pp YoY
- LTMMar 2026
- -57.7%-35.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -80.0 pp | -4.0 pp | +76.0 pp |
| 1 year | -47.8 pp | +11.4 pp | +59.2 pp |
| 3 years | +0.1 pp | +63.5 pp | +63.5 pp |
| 5 years | +80.2 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -28.9%
- Year-over-year change
- -47.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -28.9% | -47.8pp |
| FY2024 | 2024-12-31 | 18.9% | +56.5pp |
| FY2023 | 2023-12-31 | -37.6% | -8.6pp |
| FY2022 | 2022-12-31 | -29.0% | -17.9pp |
| FY2021 | 2021-12-31 | -11.1% | — |
EBITDA Margin vs competitors
How VALN compares with its peers on the latest reported figures
- VALN's LTM Mar 2026 EBITDA Margin of -57.7% is the 2nd highest of the 7 companies compared; the peer median is -349.8%.
- Its year-over-year change of -35.6 pp is the 3rd highest of 7, against a peer median of -76.0 pp.
- Over three fiscal years its change of +0.1 pp compares with a peer median of -142.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -7.1% | -51.3 pp | +81.6 pp | |
| LTM Mar 2026 | -57.7% | -35.6 pp | +0.1 pp | |
| LTM Sep 2026 | -97.2% | +35.0 pp | -184.1 pp | |
| LTM Mar 2026 | -148.9% | -100.7 pp | -100.7 pp | |
| LTM Sep 2026 | -550.8% | -269.0 pp | +146419.7 pp | |
| LTM Mar 2026 | -669.6% | +2109.2 pp | -668.6 pp | |
| FY2025 | -125425.9% | -77690.7 pp | -122786.1 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding VALN) | -349.8% | -76.0 pp | -142.4 pp | |
Competitors are the stored peer set for VALN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 348.09M | 361.3M | 153.71M | 169.58M | 174.66M |
| Cost of Revenue | 187.92M | 324.44M | 100.88M | 98.54M | 107.14M |
| Gross Profit | 160.17M | 36.86M | 52.84M | 71.04M | 67.52M |
| Gross Margin | 46.0% | 10.2% | 34.4% | 41.9% | 38.7% |
| Research & Development | 173.28M | 104.92M | 59.89M | 74.14M | 85.3M |
| Selling, General & Admin | 71.25M | 57.58M | 96.55M | 95.11M | 74.68M |
| Operating Expenses | 221.56M | 150.31M | 134.92M | 57.71M | 149.15M |
| Depreciation & Amortization | 14.28M | 21.04M | 17.58M | 19.59M | 21.75M |
| EBITDA | (38.74M) | (104.73M) | (57.72M) | 32.08M | (50.47M) |
| EBITDA Margin | -11.1% | -29.0% | -37.6% | 18.9% | -28.9% |
| Operating Income | (61.39M) | (113.44M) | (82.09M) | 13.33M | (81.63M) |
| Operating Margin | -17.6% | -31.4% | -53.4% | 7.9% | -46.7% |
| Interest Income | 249K | 260K | 1.21M | 2.36M | 1.8M |
| Interest Expense | 16.96M | 19.05M | 23.33M | 23.98M | 41.9M |
| Other Income / Expenses | (8.59M) | (31.37M) | (16.54M) | (24.82M) | (32.49M) |
| Income Before Tax | (69.98M) | (144.82M) | (98.63M) | (11.49M) | (114.12M) |
| Pre-Tax Margin | -20.1% | -40.1% | -64.2% | -6.8% | -65.3% |
| Income Tax Expense | 3.45M | (1.54M) | 2.8M | 761K | 1.07M |
| Net Income | (73.43M) | (143.28M) | (101.43M) | (12.25M) | (115.19M) |
| Net Margin | -21.1% | -39.7% | -66.0% | -7.2% | -66.0% |
| EPS (Basic) | (1.50) | (2.48) | (1.46) | (0.17) | (1.32) |
| EPS (Diluted) | (1.50) | (2.48) | (1.46) | (0.17) | (1.32) |
| Weighted Avg Shares | 48.81M | 57.74M | 69.47M | 70.26M | 84.09M |
| Weighted Avg Shares (Diluted) | 48.81M | 57.74M | 69.31M | 70.26M | 84.09M |
Valneva SE
NASDAQ:VALN
Intrinsic Alpha fair value
Locked
Current Price
$5.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.